# Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

> **NCT04051567** · PHASE4 · UNKNOWN · sponsor: **Ministry of Science and Technology of the People´s Republic of China** · enrollment: 425 (estimated)

## Conditions studied

- Twin Pregnancy
- Preeclampsia
- Preterm Birth
- Fetal Growth Restriction

## Interventions

- **DRUG:** Aspirin 100mg

## Key facts

- **NCT ID:** NCT04051567
- **Lead sponsor:** Ministry of Science and Technology of the People´s Republic of China
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 425 (ESTIMATED)
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051567, "Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04051567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*